Continual Reassessment Method for Partial Ordering (Q2893418): Difference between revisions

From MaRDI portal
Import240304020342 (talk | contribs)
Set profile property.
ReferenceBot (talk | contribs)
Changed an Item
 
(One intermediate revision by one other user not shown)
Property / OpenAlex ID
 
Property / OpenAlex ID: W1976972195 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Coherence principles in dose-finding studies / rank
 
Normal rank
Property / cites work
 
Property / cites work: Designs for Single- or Multiple-Agent Phase I Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Parallel Phase I/II Clinical Trial Design for Combination Therapies / rank
 
Normal rank
Property / cites work
 
Property / cites work: Confidence interval estimation subject to order restrictions / rank
 
Normal rank
Property / cites work
 
Property / cites work: Continual Reassessment Method: A Likelihood Approach / rank
 
Normal rank
Property / cites work
 
Property / cites work: Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer / rank
 
Normal rank
Property / cites work
 
Property / cites work: Non-parametric optimal design in dose finding studies / rank
 
Normal rank
Property / cites work
 
Property / cites work: Design and Analysis of Phase I Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Dose-Finding with Two Agents in Phase I Oncology Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Two‐Dimensional Dose Finding in Discrete Dose Space / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Latent Contingency Table Approach to Dose Finding for Combinations of Two Agents / rank
 
Normal rank

Latest revision as of 09:39, 5 July 2024

scientific article
Language Label Description Also known as
English
Continual Reassessment Method for Partial Ordering
scientific article

    Statements

    Continual Reassessment Method for Partial Ordering (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    20 June 2012
    0 references
    0 references
    clinical trial
    0 references
    continual reassessment method
    0 references
    dose escalation
    0 references
    dose-finding studies
    0 references
    drug combination
    0 references
    maximum tolerated dose
    0 references
    partial ordering
    0 references
    phase 1 trials
    0 references
    toxicity
    0 references
    0 references
    0 references